OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Trustees: Mr S R Cannon MBE, MCh, FRCS
Mr D I S Sweetnam FRCS
Mr J L Williams, CBE, FRCS, FDSRCS
Mr M J W Rushton
Administrator: Ben Haines
Banker: CAF Bank Ltd
Kings Hill
West Malling
Kent
ME19 4JQ
Auditor: MHA Monahans
Fortescue House
Court Street
Trowbridge
Wiltshire
BA14 8FA
Investment Manager: Sarasin & Partners LLP
Juxon House
100 St Paul's Churchyard
London
EC4M 8BU
Custodian Trustee: The Bank of New York Europe Limited

2021 2020
Number of awards granted Note 6 10 6
Total awards Note 6 529,781 £466,626
Total investment value Note 9 17,319,378 £14,524,122

13 January 2022

24 January 2022

Unrestricted Expendable Unrestricted Expendable
Distribution Endowment Total Distribution Endowment Total
Fund Fund Fund Fund
2021 2021 2021 2020 2020 2020
£ £ £ £ £ £
Income from:
Investments 2 616,513 616,513 612,188 612,188
Other 2 227 227 4,578 4,578
Total 616,740 616,740 616,766 616,766
Expenditure on:
Raising funds 3 78,025 78,025 75,811 75,811
Charitable activities 4 568,348 568,348 508,086 508,086
Total 568,348 78,025 646,373 508,086 75,811 583,897
Net income/
(expenditure) before 48,392 (78,025) (29,633) 108,680 (75,811) 32,869
gains/(losses)
Net gains/(losses) on
investments
2,913,599 2,913,599 (759,897) (759,897)
Net income/
(expenditure) and net 13 48,392 2,835,574 2,883,966 108,680 (835,708) (727,028)
movement in funds
Reconciliation of
funds:
Total funds brought
forward
13 1,077,972 13,245,804 14,323,776 969,292 14,081,512 15,050,804
Total funds carried
forward
13 1,126,364 16,081,378 17,207,742 1,077,972 13,245,804 14,323,776

13 January 2022

2021 2020
Notes £ £
Cash flow from operating activities:
Net cash used in operating activities 16 (788,985) (257,398)
Net cash used in operating activities (788,985) (257,398)
Cash flows from investing activities:
Dividends, interest and rents from investments 616,740 616,766
Proceeds from sale of investments 576,000
Purchase of investments (457,657) (774,041)
Net cash provided by investing activities 735,083 (157,275)
Change in cash and cash equivalents in the year (53,902) (414,673)
Cash and cash equivalents at the beginning of the 134,569 549,242
reporting period
Cash and cash equivalents at the end of the reporting 80,667 134,569
period

Unrestricted
Distribution
Fund
Total
2021
Un restricted
Distribution
Fund
Total
2020
£ £ £ £
Dividends received 616,513 616,513 612,188 612,188
Interest received 227 227 4,517 4,517
Other investment income 61 61
616,740 616,740 616,766 616,766

Expendable
Endowment
Fund
Total
2021
Expendable
Endowment
Fund
Total
2020
£ £ £ £
Investment managementfees 77,922 77,922 75,717 75,717
Bank charges 103 103 94 94
78,025 78,025 75,811 75,811

Grants to Support Total Grants to Support Total
institutions costs 2021 institutions costs 2020
£ £ £ £ £ £
Funded from unrestricted 529,781 38,567 568,348 466,626 41,460 508,086
distribution fund
529,781 38,567 568,348 466,626 41,460 508,086
Other
support
costs
Governance
costs
Total
allocated
2021
Other
support
costs
Governance
costs
Total
allocated
2020
£ £ £ £ £ £
Accountancy 16,216 16,216 32,432 15,900 15,900 31,800
Audit fees 6,135 6,135 5,880 5,880
Other costs 3,780 3,780
16,216 22,351 38,567 15,900 25,560 41,460

6 Analysis of grants payable
Other Buildings
Research charitable and Total Total
costs endeavours equipment 2021 2020
£ £ £ £ £
Reconciliation of grants payable:
Commitments at 1 April 331,181 331,181
Commitments made during the year:
Antibiotic Research UK 15,000 15,000 15,000
Bloodwise 10,000
University of Cambridge 264,000 264,000 235,000
King's College London 110,521
The Royal Marsden Cancer Charity 92,105
The Row UK Foundation 4,000
Royal College ofSurgeons 75,000 75,000
Royal College ofAnaesthetists 53,220 53,220
Northamptonshire Rape Crisis 10,000 10,000
INSPIRE Foundation 22,252 22,252
Stroke Association 38,309 38,309
The Royal Hospital for Neuro Disability 30,000 30,000
DKMS (Delete Blood Cancer) 2,000 2,000
Care for Veterens 20,000 20,000
Total commitments made in year 499,781 30,000 529,781 466,626
Total commitments made 830,962 30,000 860,962 466,626
Grants paid during the year (645,846) (30,000) (675,846) (135,445)
Commitments at 31 March 185,116 185,116 331,181

2021 2020
£ £
Within one year 91,116 146,065
Between two and five years 94,000 185,116
185,116 331,181

This is stated after charging:
2021 2020
£ £
Auditors' remuneration 6,135 5,880
Investments
2021 2020
£ £
Marketvalue at 1 April 14,524,122 14,509,978
Acquisitions at cost 457,657 774,041
Disposal proceeds (576,000)
Net realised and unrealised gains/(losses) in the 2,913,599 (759,857)
year
Marketvalue at 31 March 17,319,378 14,524,122
Historic costvalue at end ofyear 13,111,085 13,210,455

Level 1 Total
£ £
Investments listed on stock exchange 17,243,664 17,243,664
Cash held in the portfolio 75,714 75,714
17,319,378 17,319,378
The analysis at 31 March 2020was as follows:
Level 1 Total
£ £
Investments listed on stock exchange 14,478,350 14,478,350
Cash held in the portfolio 45,772 45,772
14,524, 122 14,524,122
Investment risks

INVESTMENTS 2021 2020 Direct Indirect
£ £
Fixed Income 2,621,746 2,655,934 Credit Other, Interest
UK Equities 11,788,785 2,414,618 Credit Other
Global Equities - 6,694,978 Credit Other, Currency
Property 386,552 427,147 Credit Other
Alternative Investments 1,384,429 1,393,666 Credit Other
Liquid Assets 1,205,095 937,779 Credit Interest

2021 2020
£ £
Accrued income 31,937 27,255
31,937 27,255
Creditors
2021 2020
Amounts falling due within one year: £ £
Accruals 39,124 30,989
Grants payable (note 6) 91,116 146,065
130,240 177,054
Amounts falling due after one year:
Grants payable (note 6) 94,000 185,116
Total creditors 224,240 362,170
Financial instruments
2021 2020
£ £
Financial assets measured at fair value through statement of 17,319,378 14,524,122
financial activities (note 9)

Balance
b/fwd
2021
Income
2021
Expenditure
2021
Gains
2021
Balance
c/fwd
2021
£ £ £ £ £
Expendable endowment funds
Expendable endowmentfunds 13,245,804 (78,025) 2,913,599 16,081,378
Total expendable endowment funds 13,245,804 (78,025) 2,913,599 16,081,378
Unrestricted distribution funds
Unrestricted distribution funds 1,077,972 616,740 (568,348) 1,126,364
Total unrestricted distribution funds 1,077,972 616,740 (568,348) 1,126,364
Total funds 14,323,776 616,740 (646,373) 2,913,599 17,207,742
Balance
b/fwd
2020
Income
2020
Expenditure
2020
Losses
2020
Balance
c/fwd
2020
£ £ £ £ £
Expendable endowment funds
Expendable endowmentfunds 14,081,512 (75,811) (759,897) 13,245,804
Total expendable endowment funds 14,081,512 (75,811) (759,897) 13,245,804
Unrestricted distribution funds
Unrestricted distribution funds 969,292 616,766 (508,086) 1,077,972
Total unrestricted distribution funds 969,292 616,766 (508,086) 1,077,972
Total funds 15,050,804 616,766 (583,897) (759,897) 14,323,776

Net current
assets/ Non-current
Fixed assets (liabilities) liabilities Total
2021 2021 2021 2021
£ £ £ £
Expendable endowment funds 16,407,731 (326,353) - 16,081,378
Unrestricted distribution funds 911,647 308,717 (94,000) 1,126,364
17,319,378 (17,636) (94,000) 17,207,742
Net current
assets/ Non-current
Fixed assets (liabilities) liabilities Total
2020 2020 2020 2020
£ £ £ £
Expendable endowment funds 13,722,255 (476,451) - 13,245,804
Unrestricted distribution funds 801,867 461,221 (185,116) 1,077,972
14,524,122 (15,230) (185,116) 14,323,776
2021 2020
£ £
Net income/(expenditure) forthe year (as perthe 2,883,966 (727,028)
statement offinancial activities)
Adjustments for:
Dividends, interest and rents from investments (616,740) (616,766)
Net realised and unrealised gains/(losses) in the 2,913,599 (759,857)
year
(646,373) (583,897)
(lncrease}/decrease in debtors (4,682)
(Decrease)/ Increase in creditors (137,930) 326,499
Net cash used in operating activities (788,985) (257,398)

1 April 2020 Cash flows 31 March 2021
£ £ £
Cash at bank and in hand 1,333 12,105 13,438
Cash held by investment managers 133,236 (66,007) 67,229
134,569 (53,902) 80,667